Hyperthyroid disease can have many causes, including autoimmune disease, disorders of the pituitary or hypothalmus, or tumors. The end result of any of these causes is overrelease of the thyroid hormone T4 into the blood stream, which in turn over-stimulates the body's metabolism, causing symptoms such as fevers, rapid heart rate, and weight loss. Treatment depends on proper diagnosis of the underlying cause.

Complimentary and alternative treatments for Grave's disease that are considered below include:




Differential Diagnosis


Conventional Treatment

Treatment depends on proper diagnosis of the underlying cause. If the underlying cause cannot be resolved, then it is often necessary to destroy all or part of the thyroid gland in order to prevent life-threatening complications.

Complimentary and Alternative Treatments

Complementary treatments aimed at mitigating the side-effects of conventional treatments and optimizing the immune system response are often employed by naturopathic medical doctors, and supplement rather than replace conventional medical treatment.

Alternative treatments that replace conventional medical treatment are not approved by the FDA, but may be based on traditional or historical theories and practice. Their safety and effectivenes is considered unproven by conventional medical authorities, despite theoretical, anecdotal or historical evidence.

Since complimentary and alternative treatments are not generally proven by double-blind placebo-controlled randomized clinical trials, insurance typically does not cover these treatments, although medical savings accounts may possibly be used.

Low Dose Naltrexone

The use of Low Dose Naltrexone (LDN) in treating autoimmune, neuroinflammatory, and certain microbial diseases and cancers was pioneered by the late Dr. Bernard Bihari [Bihari2003], [Bihari2013].

[LdnResearchTrust_conditions] reports that Grave's disease is a condition that LDN could help. Please see [LDN_Story] for an excellent documentary video, and [Elsegood2016] and [Moore2008] for books.

Dr. Weyrich notes that these reports are considered anecdotal, and without expensive double-blind placebo-controlled trials (which are unlikely to be funded, since LDN is a generic drug that cannot be patented), these results cannot be provento be anything more than "spontaneous remissions"; however, given the low cost (less than $40/month) and extremely low side-effect profile, a therapeutic trial may be in order.

It is believed [LDN] that LDN works by temporarily blocking the body's opioid receptors, which induces a reflex increase in the body's natural endorphin and enkephalin levels, which then modulates the immune system to restore balance and reduce inflammation. However, [Younger2014] has proposed an alternative mechanism in which naltrexone exerts an antagonist effect on Toll-like receptor 4 (TLR4) that are found on macrophages and microglia; additional mechanisms involving astrocytes, NADPH oxidase 2, and the opioid growth factor receptor (OGFr) have also been proposed. The result is reduced neuroinflammation, which is generally associated with all neurodegenerative diseases.

The main caveats are that patients cannot also be being treated with extended release opiates for pain control and cannot be organ transplant recipients. This is an off-label use, and as such is not likely to be covered by insurance.

Dr. Weyrich has been trained in the use of Low Dose Naltrexone (LDN) and offers these protocols as a complement to other therapies; however at this time Dr. Weyrich has not treated any cases of Grave's disease using LDN.

Neurotransmitter Balancing

Neuro Research [Hinz2015] reports that chronic diseases such as Grave's Disease can be benefited by balancing neurotransmitter and sulfur-containing amino acid levels in the body, particularly serotonin, dopamine, and cysteine, through targeted nutrition guided by lab testing. Dr. Weyrich has been trained in the Neuro-Research protocols and offers these nutritional protocols as a complement to other therapies.

Note that nutritional supplements and testing are not covered by most insurance policies, but may be eligible for payment out of Health Care Savings Accounts.